This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Choosing a rollover path between SP 500 ETF and Index Fund involves evaluating taxes, costs, and flexibility to support your retirement goals.
23,894 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Rocket Lab is tightening revenue visibility with a growing backlog and stronger margins entering 2026. Analysts eye h...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
A corporate insider sold a meaningful chunk of stock after a record revenue year. This article breaks down what such ...
After a stunning quarterly update, Micron stock tumbled on fears about memory cycles. This guide breaks down why the ...
MIAX is shaping 2026 in a dynamic way, and the first-quarter earnings transcript offers clues about growth drivers an...
Clorox has stacked a long streak of dividend increases, but reaching 50 years could hinge on a crucial strategic shif...
Pangaea (PANL) 2026 earnings narrative hinges on revenue growth, margin expansion, and cash flow strength. This guide...
A sweeping study ties two decades of bat die-offs to rising crop damages, heavier local taxes, and pricier debt for r...
AST SpaceMobile posted a Q1 2026 revenue miss but reaffirmed full-year guidance and outlined a rapid satellite deploy...
NextEra Energy is set to buy Dominion Energy in a $67 billion all-stock deal aimed at securing power capacity for AI-...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...